|
Match
|
Document |
Document Title |
|
|
US20090176762 |
JNK Inhibitors for Treatment of Skin Diseases
This invention relates to the use of a JNK inhibitor for treating and/or preventing skin diseases selected from psoriasis and dermatitis.
|
|
|
US20090176761 |
JNK Inhivitors for the Treatment of Endometriosis
This invention relates to a method of treating and/or preventing endometriosis comprising administering a JNK inhibitor. The JNK inhibitor can also be administered combined with a hormonal...
|
|
|
US20090054396 |
SUBSTITUTED THIOPHENES AND USES THEREOF
This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical salts, compositions and methods of use. These novel compounds provide a treatment or...
|
|
|
US20090036428 |
AGENT FOR TREATING OR PREVENTING DIGESTIVE ULCER
An object of the present invention is to provide an agent for treating or preventing digestive ulcer that is effective even to ulcer of small intestine and others, for which gastric acid secretion...
|
|
|
US20080306047 |
Use of Aza-Phenylalanine Compounds For Treating Cardiac Arrhythmia
The present invention relates to the use of certain aza-phenylalanine compounds of formula (I) wherein R 1 denotes amino, alkylamino, dialkylamino, amidino, alkylamidino, N-hydroxyamidino, or...
|
|
|
US20080260837 |
Physically stable aqueous suspensions of active pharmaceuticals
The present invention concerns methods of making physically stable aqueous suspensions of sparingly soluble to insoluble in water, active pharmaceuticals. More particularly, the invention provides...
|
|
|
US20080146545 |
Macrocyclic compounds useful as inhibitors of kinases and HSP90
Disclosed are macrocyclic compounds of formulae I-V, which are analogs of the pochonin resorcylic acid lactones, and processes for the preparation of the compounds. The compounds disclosed are...
|
|
|
US20080113945 |
COMPOSITIONS AND METHODS FOR INHIBITING CYTOCHROME P450
Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450....
|